Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Christine Walsh

Concepts (363)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
50
2024
562
8.270
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
6
2024
115
2.210
 Why?
Neoplasms, Glandular and Epithelial
12
2022
49
2.100
 Why?
Endometrial Neoplasms
11
2022
199
2.030
 Why?
BRCA1 Protein
8
2020
76
1.660
 Why?
BRCA2 Protein
8
2021
63
1.660
 Why?
Genes, BRCA1
10
2023
38
1.390
 Why?
Genes, BRCA2
9
2023
29
1.380
 Why?
Peritoneal Neoplasms
4
2018
93
1.230
 Why?
Adenocarcinoma, Clear Cell
4
2016
14
1.210
 Why?
Cystadenocarcinoma, Serous
9
2019
75
1.090
 Why?
Biomarkers, Tumor
8
2022
1272
0.940
 Why?
Maintenance Chemotherapy
2
2024
35
0.920
 Why?
Neoplasm Recurrence, Local
13
2024
1058
0.870
 Why?
Germ-Line Mutation
6
2016
172
0.850
 Why?
Indazoles
2
2020
69
0.830
 Why?
Bevacizumab
2
2020
135
0.820
 Why?
Neoplasm Staging
14
2021
1373
0.810
 Why?
Piperidines
2
2020
206
0.750
 Why?
Myeloproliferative Disorders
1
2021
27
0.740
 Why?
Sleep, REM
2
2023
33
0.720
 Why?
Polymorphism, Single Nucleotide
15
2018
2184
0.690
 Why?
Gray Matter
1
2021
80
0.680
 Why?
Phthalazines
1
2020
45
0.680
 Why?
Sleep Apnea Syndromes
1
2021
88
0.670
 Why?
Female
75
2024
72785
0.670
 Why?
Genetic Predisposition to Disease
15
2023
2412
0.660
 Why?
Deoxycytidine
1
2021
179
0.660
 Why?
Aged, 80 and over
23
2021
7593
0.630
 Why?
Cisplatin
1
2021
320
0.620
 Why?
Mutation
14
2023
3947
0.620
 Why?
Fallopian Tube Neoplasms
2
2016
17
0.610
 Why?
Genital Neoplasms, Female
3
2018
89
0.610
 Why?
White Matter
2
2020
145
0.610
 Why?
Piperazines
2
2020
350
0.600
 Why?
Medical Oncology
2
2020
288
0.600
 Why?
Molecular Targeted Therapy
3
2017
411
0.600
 Why?
Breast Neoplasms
11
2023
2234
0.590
 Why?
Sleep Initiation and Maintenance Disorders
1
2021
165
0.590
 Why?
Tumor Suppressor Protein p53
1
2022
528
0.590
 Why?
Genetic Testing
3
2017
453
0.580
 Why?
Gynecology
1
2020
168
0.580
 Why?
Antineoplastic Agents
3
2018
2123
0.540
 Why?
Aged
37
2021
23800
0.540
 Why?
Thromboplastin
1
2017
74
0.540
 Why?
Fellowships and Scholarships
1
2020
303
0.530
 Why?
Humans
81
2024
136750
0.520
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
2
2023
35
0.510
 Why?
DNA Repair-Deficiency Disorders
1
2016
4
0.500
 Why?
Digoxin
1
2015
30
0.490
 Why?
Antibodies, Monoclonal, Humanized
1
2021
801
0.480
 Why?
Venous Thrombosis
1
2017
190
0.460
 Why?
Carcinoma, Endometrioid
2
2014
50
0.440
 Why?
DNA-Binding Proteins
3
2012
1501
0.440
 Why?
Hysterectomy
4
2009
128
0.430
 Why?
Prognosis
16
2022
4012
0.430
 Why?
Organoplatinum Compounds
2
2015
46
0.420
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2021
1684
0.420
 Why?
Middle Aged
39
2021
33225
0.410
 Why?
Survival Rate
9
2021
1962
0.410
 Why?
Cognition
1
2020
1146
0.390
 Why?
Enzyme Inhibitors
1
2016
839
0.380
 Why?
Loss of Heterozygosity
2
2008
51
0.370
 Why?
Cystadenocarcinoma, Papillary
2
2008
5
0.370
 Why?
Nuclear Proteins
4
2016
712
0.370
 Why?
Adenocarcinoma, Papillary
1
2011
12
0.360
 Why?
Ovariectomy
4
2023
152
0.340
 Why?
Neoplasms, Multiple Primary
2
2014
57
0.340
 Why?
Internship and Residency
1
2020
1127
0.330
 Why?
Alzheimer Disease
3
2023
559
0.330
 Why?
DNA, Neoplasm
4
2014
164
0.330
 Why?
DNA Repair
1
2011
231
0.310
 Why?
Venous Thromboembolism
1
2013
313
0.310
 Why?
Indoles
2
2024
410
0.310
 Why?
Platinum
2
2021
49
0.310
 Why?
Uniparental Disomy
1
2008
9
0.300
 Why?
Uterine Neoplasms
4
2014
109
0.300
 Why?
Transcription Factors
4
2016
1718
0.290
 Why?
Endonucleases
1
2008
32
0.290
 Why?
Adult
31
2021
37626
0.290
 Why?
Homologous Recombination
2
2020
26
0.290
 Why?
Disease-Free Survival
5
2013
686
0.280
 Why?
CA-125 Antigen
2
2021
14
0.270
 Why?
Risk Factors
14
2023
10330
0.270
 Why?
Drug Resistance, Neoplasm
4
2022
800
0.260
 Why?
Neoplasms
1
2021
2643
0.260
 Why?
Proto-Oncogene Proteins c-mdm2
1
2006
65
0.250
 Why?
Checkpoint Kinase 2
2
2016
29
0.250
 Why?
United States
7
2024
14682
0.250
 Why?
Surgical Wound Infection
1
2009
305
0.240
 Why?
Vaginal Neoplasms
2
2016
18
0.240
 Why?
Survival Analysis
5
2017
1321
0.240
 Why?
Obesity, Morbid
1
2009
259
0.230
 Why?
Anisotropy
3
2020
79
0.230
 Why?
Drug Approval
1
2024
87
0.220
 Why?
United States Food and Drug Administration
1
2024
208
0.210
 Why?
Neoplasms, Unknown Primary
1
2023
19
0.200
 Why?
Medicare
2
2020
756
0.200
 Why?
Neoplasm Grading
7
2019
305
0.190
 Why?
DNA Methylation
2
2022
640
0.190
 Why?
Lewy Body Disease
1
2022
29
0.190
 Why?
ras Proteins
2
2015
153
0.190
 Why?
Transforming Growth Factor beta
2
2016
480
0.190
 Why?
Immunohistochemistry
3
2019
1733
0.190
 Why?
Molecular Diagnostic Techniques
1
2022
105
0.180
 Why?
Case-Control Studies
6
2017
3540
0.180
 Why?
Endometriosis
1
2022
50
0.180
 Why?
Diffusion Magnetic Resonance Imaging
2
2020
153
0.180
 Why?
Poly (ADP-Ribose) Polymerase-1
1
2021
50
0.180
 Why?
Sleep Wake Disorders
2
2023
283
0.180
 Why?
Computing Methodologies
1
2020
3
0.180
 Why?
Thrombocytosis
2
2014
6
0.170
 Why?
Leydig Cell Tumor
1
2020
8
0.170
 Why?
Benzamides
1
2021
216
0.170
 Why?
Hyperandrogenism
1
2020
21
0.170
 Why?
Population Surveillance
3
2020
473
0.170
 Why?
Adaptor Proteins, Signal Transducing
2
2016
429
0.170
 Why?
Diffusion
1
2020
116
0.160
 Why?
Optical Imaging
1
2020
61
0.160
 Why?
Retrospective Studies
13
2020
15499
0.160
 Why?
Genome-Wide Association Study
6
2022
1428
0.160
 Why?
Proto-Oncogene Proteins
2
2015
647
0.160
 Why?
Cell Line, Tumor
4
2016
3406
0.160
 Why?
Fitness Trackers
1
2019
12
0.150
 Why?
Drug Administration Schedule
1
2021
785
0.150
 Why?
B7-H1 Antigen
1
2021
217
0.150
 Why?
Risk Reduction Behavior
2
2018
218
0.150
 Why?
Early Ambulation
1
2019
24
0.150
 Why?
Dementia
1
2022
256
0.150
 Why?
Rho Guanine Nucleotide Exchange Factors
1
2018
25
0.150
 Why?
Monomeric GTP-Binding Proteins
1
2018
14
0.150
 Why?
Antineoplastic Agents, Immunological
1
2020
188
0.150
 Why?
Angiogenesis Inhibitors
1
2020
226
0.140
 Why?
Carcinoma in Situ
2
2016
49
0.140
 Why?
Cost-Benefit Analysis
1
2020
587
0.140
 Why?
Regression Analysis
1
2020
1022
0.140
 Why?
A Kinase Anchor Proteins
1
2018
72
0.140
 Why?
Enzyme Multiplied Immunoassay Technique
1
2017
2
0.140
 Why?
Cadherins
1
2019
205
0.140
 Why?
Postoperative Care
1
2019
261
0.130
 Why?
Randomized Controlled Trials as Topic
2
2020
1462
0.130
 Why?
Genetic Counseling
1
2017
77
0.130
 Why?
Remission Induction
1
2017
288
0.130
 Why?
Salpingectomy
1
2016
13
0.130
 Why?
Parkinson Disease
1
2022
490
0.130
 Why?
Receptors, Transforming Growth Factor beta
1
2016
59
0.130
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2016
66
0.130
 Why?
Oligonucleotide Array Sequence Analysis
2
2008
766
0.130
 Why?
Lymphocyte Activation
1
2020
1150
0.130
 Why?
Phosphotransferases (Alcohol Group Acceptor)
1
2016
45
0.120
 Why?
Extracellular Matrix Proteins
2
2015
153
0.120
 Why?
Antigens, CD
1
2019
521
0.120
 Why?
Los Angeles
2
2018
76
0.120
 Why?
Clinical Trials as Topic
2
2013
1044
0.120
 Why?
Cohort Studies
6
2016
5703
0.120
 Why?
Chemotherapy, Adjuvant
1
2016
389
0.120
 Why?
Cyclin E
1
2015
25
0.120
 Why?
Genotype
6
2018
1914
0.120
 Why?
Gonadotropins
1
2014
40
0.110
 Why?
Proto-Oncogene Proteins c-ets
1
2015
56
0.110
 Why?
SEER Program
1
2015
218
0.110
 Why?
Oncogene Proteins
1
2015
59
0.110
 Why?
Lymph Node Excision
1
2016
170
0.110
 Why?
Enhancer Elements, Genetic
1
2016
190
0.110
 Why?
Myofibroblasts
1
2016
126
0.110
 Why?
Corpus Callosum
1
2014
70
0.110
 Why?
Tumor Suppressor Proteins
1
2016
327
0.110
 Why?
Early Detection of Cancer
3
2021
417
0.110
 Why?
TNF-Related Apoptosis-Inducing Ligand
1
2013
51
0.110
 Why?
Cancer Survivors
1
2018
280
0.110
 Why?
Promoter Regions, Genetic
2
2010
1249
0.110
 Why?
Interleukin-1alpha
1
2013
58
0.100
 Why?
ATP-Binding Cassette Transporters
1
2014
137
0.100
 Why?
Cognitive Dysfunction
1
2018
381
0.100
 Why?
Heterozygote
4
2016
292
0.100
 Why?
Length of Stay
1
2019
1204
0.100
 Why?
Treatment Outcome
4
2021
10747
0.100
 Why?
Patient Satisfaction
1
2017
656
0.100
 Why?
Lymph Nodes
1
2016
492
0.100
 Why?
Time Factors
3
2021
6808
0.100
 Why?
Prefrontal Cortex
1
2016
304
0.100
 Why?
Brain Mapping
1
2016
504
0.100
 Why?
Receptor Protein-Tyrosine Kinases
1
2015
234
0.100
 Why?
Cell Adhesion Molecules
1
2013
181
0.100
 Why?
Adenocarcinoma
2
2011
938
0.100
 Why?
Chromosomes, Human, Pair 19
1
2012
25
0.100
 Why?
Health Care Reform
1
2013
105
0.090
 Why?
Gene Expression Regulation, Neoplastic
4
2016
1396
0.090
 Why?
Endometrial Hyperplasia
1
2011
8
0.090
 Why?
Terminal Care
1
2015
230
0.090
 Why?
T-Lymphocytes
1
2020
1993
0.090
 Why?
Follow-Up Studies
5
2016
5105
0.090
 Why?
Chromosomes, Human
1
2011
44
0.090
 Why?
Progestins
1
2011
78
0.090
 Why?
Magnetic Resonance Imaging
2
2021
3556
0.090
 Why?
Executive Function
1
2016
440
0.090
 Why?
Surveys and Questionnaires
2
2021
5739
0.090
 Why?
Male
9
2021
67305
0.090
 Why?
Fibroblasts
1
2016
993
0.090
 Why?
Prostatic Neoplasms
2
2016
1034
0.080
 Why?
Mass Screening
2
2010
1266
0.080
 Why?
Real-Time Polymerase Chain Reaction
3
2016
346
0.080
 Why?
MutL Protein Homolog 1
1
2010
12
0.080
 Why?
Genetic Association Studies
3
2018
375
0.080
 Why?
Interleukin-6
1
2014
778
0.080
 Why?
Sleep
3
2023
753
0.080
 Why?
Mammography
2
2021
152
0.080
 Why?
Microsatellite Instability
1
2010
42
0.080
 Why?
NF-kappa B
1
2013
691
0.080
 Why?
Leiomyomatosis
1
2009
6
0.080
 Why?
Receptors, Estrogen
1
2012
436
0.080
 Why?
Suction
1
2009
34
0.080
 Why?
Incidence
4
2021
2797
0.080
 Why?
Signal Transduction
4
2016
5077
0.080
 Why?
Protein Kinase Inhibitors
1
2015
916
0.070
 Why?
Artifacts
1
2009
129
0.070
 Why?
Carcinoma, Papillary
1
2009
81
0.070
 Why?
Polymerase Chain Reaction
1
2011
1059
0.070
 Why?
Adenocarcinoma, Mucinous
1
2009
80
0.070
 Why?
Cell Differentiation
1
2016
1982
0.070
 Why?
Alleles
1
2011
890
0.070
 Why?
Ovary
2
2020
221
0.070
 Why?
Conization
1
2007
1
0.070
 Why?
Registries
1
2015
2014
0.070
 Why?
Blood Vessels
1
2009
187
0.070
 Why?
Gynecologic Surgical Procedures
1
2007
63
0.070
 Why?
Risk
3
2016
908
0.070
 Why?
Pseudogenes
1
2006
18
0.060
 Why?
Healthcare Disparities
1
2013
649
0.060
 Why?
Fertility
1
2007
159
0.060
 Why?
Pilot Projects
2
2022
1693
0.060
 Why?
Genes, Tumor Suppressor
1
2005
86
0.060
 Why?
Lymphoma
1
2006
208
0.060
 Why?
Quantitative Trait Loci
2
2018
380
0.060
 Why?
Kaplan-Meier Estimate
2
2019
888
0.060
 Why?
Laparoscopy
1
2009
464
0.060
 Why?
Membrane Proteins
1
2011
1163
0.060
 Why?
Uterine Cervical Neoplasms
1
2007
254
0.060
 Why?
MicroRNAs
1
2011
692
0.050
 Why?
Phosphatidylinositol 3-Kinases
1
2006
366
0.050
 Why?
Tumor Cells, Cultured
2
2016
953
0.050
 Why?
Aging
1
2014
1863
0.050
 Why?
Leukemia
1
2006
238
0.050
 Why?
Neoplasm Invasiveness
2
2019
507
0.050
 Why?
Genetic Loci
2
2015
288
0.050
 Why?
Immunoenzyme Techniques
2
2016
219
0.050
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
975
0.050
 Why?
RNA, Messenger
3
2016
2831
0.050
 Why?
Gene Expression
1
2008
1500
0.050
 Why?
Age Factors
1
2010
3286
0.050
 Why?
Muscle Hypertonia
1
2022
8
0.050
 Why?
Sensitivity and Specificity
1
2007
1936
0.050
 Why?
Transcriptome
2
2022
969
0.050
 Why?
Linear Models
2
2015
845
0.050
 Why?
Algorithms
1
2010
1688
0.050
 Why?
Practice Guidelines as Topic
1
2010
1569
0.050
 Why?
Proto-Oncogene Proteins p21(ras)
2
2015
267
0.050
 Why?
Chromatin Immunoprecipitation
2
2016
138
0.040
 Why?
Diagnosis, Differential
2
2016
1480
0.040
 Why?
Virilism
1
2020
7
0.040
 Why?
Sleep Deprivation
1
2023
174
0.040
 Why?
Neuropsychological Tests
2
2016
1022
0.040
 Why?
Prospective Studies
3
2019
7572
0.040
 Why?
Young Adult
2
2016
13126
0.040
 Why?
Cell Movement
2
2016
968
0.040
 Why?
California
1
2021
429
0.040
 Why?
Epigenesis, Genetic
1
2005
657
0.040
 Why?
Mastectomy
1
2020
136
0.040
 Why?
Ribonucleoproteins, Small Nucleolar
1
2019
4
0.040
 Why?
Cell Proliferation
2
2016
2476
0.040
 Why?
Fanconi Anemia Complementation Group N Protein
1
2016
5
0.030
 Why?
Testosterone
1
2020
401
0.030
 Why?
Apoptosis
2
2016
2552
0.030
 Why?
Ultrasonography
1
2020
750
0.030
 Why?
Receptors, Lysosphingolipid
1
2016
15
0.030
 Why?
Databases, Factual
1
2021
1351
0.030
 Why?
Behavior Therapy
1
2018
258
0.030
 Why?
Electrophoretic Mobility Shift Assay
1
2016
85
0.030
 Why?
Sphingosine
1
2016
46
0.030
 Why?
Models, Anatomic
1
2016
92
0.030
 Why?
Lysophospholipids
1
2016
80
0.030
 Why?
Gene Frequency
1
2016
520
0.030
 Why?
Apathy
1
2015
7
0.030
 Why?
Disease Progression
2
2016
2751
0.030
 Why?
Factor Analysis, Statistical
1
2016
283
0.030
 Why?
Aurora Kinase A
1
2015
56
0.030
 Why?
Fluorescent Antibody Technique
1
2016
388
0.030
 Why?
E2F Transcription Factors
1
2015
60
0.030
 Why?
Oxazoles
1
2015
37
0.030
 Why?
Hyaluronan Receptors
1
2015
103
0.030
 Why?
Likelihood Functions
1
2015
143
0.030
 Why?
Mammary Glands, Human
1
2015
64
0.030
 Why?
ATP Binding Cassette Transporter 1
1
2014
10
0.030
 Why?
Neurologic Examination
1
2015
110
0.030
 Why?
Lymphatic Metastasis
1
2016
351
0.030
 Why?
Thiazoles
1
2015
123
0.030
 Why?
Nucleotides
1
2015
124
0.030
 Why?
Phenotype
1
2023
3189
0.030
 Why?
Random Allocation
1
2015
353
0.030
 Why?
Electronic Health Records
1
2021
1045
0.030
 Why?
Tubulin
1
2015
140
0.030
 Why?
Genetic Markers
1
2014
344
0.030
 Why?
Cyclin-Dependent Kinases
1
2015
132
0.030
 Why?
Microtubule-Associated Proteins
1
2015
194
0.030
 Why?
Microarray Analysis
1
2013
116
0.030
 Why?
Estrogen Receptor alpha
1
2015
145
0.030
 Why?
T-Lymphocytes, Regulatory
1
2016
387
0.030
 Why?
DNA Mutational Analysis
1
2014
399
0.030
 Why?
Memory, Short-Term
1
2016
249
0.030
 Why?
Age of Onset
1
2015
518
0.030
 Why?
Carcinogenesis
1
2015
217
0.030
 Why?
Blotting, Western
1
2016
1225
0.030
 Why?
Mice, Nude
1
2015
696
0.030
 Why?
Attention
1
2016
426
0.020
 Why?
Cells, Cultured
1
2020
4192
0.020
 Why?
Vagina
1
2014
186
0.020
 Why?
Hospice Care
1
2015
202
0.020
 Why?
Advance Care Planning
1
2015
208
0.020
 Why?
Xenograft Model Antitumor Assays
1
2015
868
0.020
 Why?
Referral and Consultation
1
2017
779
0.020
 Why?
Phosphorylation
1
2016
1758
0.020
 Why?
Chromosomes, Human, Pair 6
1
2011
52
0.020
 Why?
Premenopause
1
2011
131
0.020
 Why?
Pyridines
1
2015
506
0.020
 Why?
Biomarkers
1
2022
4145
0.020
 Why?
Chromosomes, Human, Pair 1
1
2011
71
0.020
 Why?
Cell Cycle Proteins
1
2015
613
0.020
 Why?
Evolution, Molecular
1
2015
488
0.020
 Why?
Health Personnel
1
2017
701
0.020
 Why?
Predictive Value of Tests
1
2016
2021
0.020
 Why?
3' Untranslated Regions
1
2011
145
0.020
 Why?
Precancerous Conditions
1
2011
169
0.020
 Why?
Neoplastic Stem Cells
1
2014
399
0.020
 Why?
Logistic Models
1
2014
2067
0.020
 Why?
Mice, Knockout
1
2016
3009
0.020
 Why?
Carboplatin
1
2009
142
0.020
 Why?
Transcription, Genetic
1
2015
1455
0.020
 Why?
Mice
2
2016
17758
0.020
 Why?
Multivariate Analysis
1
2011
1507
0.020
 Why?
Brachytherapy
1
2009
121
0.020
 Why?
Paclitaxel
1
2009
227
0.020
 Why?
Parity
1
2007
125
0.020
 Why?
Medical Records
1
2007
174
0.020
 Why?
Chromosomes, Human, Pair 22
1
2006
45
0.020
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2006
95
0.020
 Why?
Combined Modality Therapy
1
2009
1231
0.020
 Why?
Osteosarcoma
1
2006
74
0.020
 Why?
Lymphoma, Non-Hodgkin
1
2006
87
0.010
 Why?
CCAAT-Enhancer-Binding Protein-alpha
1
2005
15
0.010
 Why?
Exons
1
2006
351
0.010
 Why?
Pregnancy Outcome
1
2007
411
0.010
 Why?
CpG Islands
1
2005
157
0.010
 Why?
Reoperation
1
2007
573
0.010
 Why?
Methylation
1
2005
230
0.010
 Why?
Reference Values
1
2006
816
0.010
 Why?
Mediator Complex
1
2005
61
0.010
 Why?
Emergency Service, Hospital
1
2015
2047
0.010
 Why?
Bone Neoplasms
1
2006
248
0.010
 Why?
Proportional Hazards Models
1
2006
1260
0.010
 Why?
Animals
2
2016
36836
0.010
 Why?
Histones
1
2005
636
0.010
 Why?
Leukemia, Myeloid, Acute
1
2006
622
0.010
 Why?
Pregnancy
1
2007
6727
0.010
 Why?
Walsh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (363) concept(s)
_
Co-Authors Expand Description
See all (5) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)